COCH

Envoy Medical, Inc. COCH

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,914 of 2,925

Why it scores 6Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$51.0K

Quarter to Jun 30

Net income

$-5.98M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$14.27M total
Nantahala Capital Management, LLC
$5.96M0.0%
Bleichroeder LP
$4.95M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$697.1K-0.2%
DSG Capital Advisors, LLC
$474.2K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$429.1K+3.8%
Focus Partners Wealth
$336.8K+100.0%
VANGUARD FIDUCIARY TRUST CO
$235.0K+0.7%
UBS Group AG
$151.1K+170.8%
Arcus Capital Partners, LLC
$148.6K0.0%
ExodusPoint Capital Management, LP
$144.4KNew
NORTHERN TRUST CORP
$86.7K-1.4%
Oasis Management Co Ltd.
$79.2K0.0%
MORGAN STANLEY
$72.0K+23.0%
CIBC Bancorp USA Inc.
$61.7K0.0%
ARISTEIA CAPITAL, L.L.C.
$54.2K0.0%
LPL Financial LLC
$38.3K+70.4%
JANE STREET GROUP, LLC
$35.1K+15.0%
TORONTO DOMINION BANK
$26.7K0.0%
Athos Capital Ltd
$23.0K0.0%
METEORA CAPITAL, LLC
$22.2K0.0%
STATE STREET CORP
$18.9K0.0%
Clear Street Group Inc.
$15.0K0.0%
BNP PARIBAS FINANCIAL MARKETS
$14.1K0.0%
Polar Asset Management Partners Inc.
$14.1K0.0%
XTX Topco Ltd
$13.6KNew
See all 62 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/COCH

Earnings Per Share

13fpro.ai/company/COCH

Loading ratio trend…

COCH key financials by period

Reported revenue, net income and operating margin by fiscal year, from Envoy Medical, Inc.'s annual filings on SEC EDGAR.

Envoy Medical, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$241.0K$-23.8M—
FY 2024$225.0K$-20.8M—
FY 2023$316.0K$-29.9M—
FY 2022$237.0K$-15.9M—
Source: COCH filings on SEC EDGAR →

COCH insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Envoy Medical, Inc. (COCH): stock profile, AI score and financials

Envoy Medical, Inc. (COCH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores COCH at 6.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,914 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Envoy Medical, Inc. reports quarterly revenue of $51.0K, net income of $-6.0M. Top institutional holders of COCH by reported 13-F value include Nantahala Capital Management, Bleichroeder, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. COCH trades on the Nasdaq exchange and files with the SEC under CIK 1840877. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate COCH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Envoy Medical, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1840877 →